Grant Detail
This is a chronological listing of grants held by this department, with the most recent listed first. This list contains only grants that were active as of July 1, 2008, or awarded since that date. New grants appear in this list periodically and contribute to the department's fingerprint profile. The source of grants for this application comes directly from your institution.
The effect of LY2189265 on major cardiovascular events in patients with type 2 diabetes: Reducing cardiovascular events with a weekly incretin in diabetes (REWIND)
Elizabeth Seaquist
4/18/2011 - 4/17/2021| Sponsoring Organization: | Eli Lilly and Company |
| Recipient Organization: | University of Minnesota |
Elizabeth R Seaquist (PI)